STOCK TITAN

XTL Biopharmaceuticals Ltd. American (XTLB) Free Cash Flow by Year

XTLB

XTL Biopharmaceuticals Ltd. American recorded an outflow of $1.1M in free cash flow in fiscal year 2025. This represents an increase of 35.5% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters XTL Biopharmaceuticals Ltd. American has filed alongside them.

FY2025 annual
Free Cash Flow -$1.1M
YoY +35.5%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

XTLB Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
Free Cash Flow-$1.1M+35.5%-$1.7MN/AN/AN/A-$851K+6.5%-$910KN/AN/A-$1.7M+6.9%-$1.9M

XTLB Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2510-KQ1'2510-KQ2'2410-KQ2'2310-KQ4'2210-KQ2'2210-KQ4'2110-KQ2'2110-KQ4'2010-KQ2'2010-KQ2'1910-KQ2'1810-K
Free Cash FlowN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More XTL Biopharmaceuticals Ltd. American financials

Frequently Asked Questions

What was XTL Biopharmaceuticals Ltd. American's free cash flow in fiscal year 2025?

XTL Biopharmaceuticals Ltd. American recorded an outflow of $1.1M in free cash flow in fiscal year 2025.

How fast is XTL Biopharmaceuticals Ltd. American's free cash flow growing?

XTL Biopharmaceuticals Ltd. American (XTLB) free cash flow rose by 35.5% year over year, from -$1.7M to -$1.1M in fiscal year 2025.

How has XTL Biopharmaceuticals Ltd. American's free cash flow changed over the years?

Across the 11 fiscal years this page covers, XTL Biopharmaceuticals Ltd. American (XTLB) free cash flow went from -$1.9M in fiscal year 2015 to -$1.1M in fiscal year 2025.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what XTL Biopharmaceuticals Ltd. American (XTLB) reported on that line in every period on record.